These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 2007360)
1. Gastroduodenal mucosal prostaglandin generation in patients with Helicobacter pylori before and after treatment with bismuth subsalicylate. Avunduk C; Suliman M; Gang D; Polakowski N; Eastwood GL Dig Dis Sci; 1991 Apr; 36(4):431-4. PubMed ID: 2007360 [TBL] [Abstract][Full Text] [Related]
2. Factors influencing the eradication of Helicobacter pylori with triple therapy. Graham DY; Lew GM; Malaty HM; Evans DG; Evans DJ; Klein PD; Alpert LC; Genta RM Gastroenterology; 1992 Feb; 102(2):493-6. PubMed ID: 1732120 [TBL] [Abstract][Full Text] [Related]
3. Eicosanoid synthesis and Helicobacter pylori associated gastritis: increase in leukotriene C4 generation associated with H. pylori colonization. Ahmed A; Holton J; Vaira D; Smith SK; Hoult JR Prostaglandins; 1992 Jul; 44(1):75-86. PubMed ID: 1641505 [TBL] [Abstract][Full Text] [Related]
4. The actions of bismuth in the treatment of Helicobacter pylori infection. Lambert JR; Midolo P Aliment Pharmacol Ther; 1997 Apr; 11 Suppl 1():27-33. PubMed ID: 9146788 [TBL] [Abstract][Full Text] [Related]
5. Improved eradication rate of standard triple therapy by adding bismuth and probiotic supplement for Helicobacter pylori treatment in Thailand. Srinarong C; Siramolpiwat S; Wongcha-um A; Mahachai V; Vilaichone RK Asian Pac J Cancer Prev; 2014; 15(22):9909-13. PubMed ID: 25520127 [TBL] [Abstract][Full Text] [Related]
6. Double-blind randomized trial of bismuth subsalicylate and clindamycin for treatment of Helicobacter pylori infection. Westblom TU; Madan E; Subik MA; Duriex DE; Midkiff BR Scand J Gastroenterol; 1992; 27(3):249-52. PubMed ID: 1502490 [TBL] [Abstract][Full Text] [Related]
7. Treatment of Campylobacter pylori-associated antral gastritis in children with bismuth subsalicylate and ampicillin. Drumm B; Sherman P; Chiasson D; Karmali M; Cutz E J Pediatr; 1988 Nov; 113(5):908-12. PubMed ID: 3183851 [TBL] [Abstract][Full Text] [Related]
8. The role of omeprazole (40 mg) in the treatment of gastric Helicobacter pylori infection. Wagner S; Varrentrapp M; Haruma K; Lange P; Müller MJ; Schorn T; Soudah B; Bär W; Gebel M Z Gastroenterol; 1991 Nov; 29(11):595-8. PubMed ID: 1771934 [TBL] [Abstract][Full Text] [Related]
9. Bismuth subsalicylate suppression of Helicobacter pylori in nonulcer dyspepsia: a double-blind placebo-controlled trial. Marshall BJ; Valenzuela JE; McCallum RW; Dooley CP; Guerrant RL; Cohen H; Frierson HF; Field LG; Jerdack GR; Mitra S Dig Dis Sci; 1993 Sep; 38(9):1674-80. PubMed ID: 8359080 [TBL] [Abstract][Full Text] [Related]
10. Bismuth subsalicylate in the treatment of H2 blocker resistant duodenal ulcers: role of Helicobacter pylori. Wagner S; Gebel M; Haruma K; Bär W; Lange P; Freise J; Gladziwa U; Schmidt FW Gut; 1992 Feb; 33(2):179-83. PubMed ID: 1347278 [TBL] [Abstract][Full Text] [Related]
11. Helicobacter pylori infection in recurrent abdominal pain in childhood: comparison of diagnostic tests and therapy. Chong SK; Lou Q; Asnicar MA; Zimmerman SE; Croffie JM; Lee CH; Fitzgerald JF Pediatrics; 1995 Aug; 96(2 Pt 1):211-5. PubMed ID: 7630671 [TBL] [Abstract][Full Text] [Related]
12. Eradication of Helicobacter pylori normalizes elevated mucosal levels of epidermal growth factor and its receptor. Coyle WJ; Sedlack RE; Nemec R; Peterson R; Duntemann T; Murphy M; Lawson JM Am J Gastroenterol; 1999 Oct; 94(10):2885-9. PubMed ID: 10520838 [TBL] [Abstract][Full Text] [Related]
13. Effect of cyclooxygenase-2 inhibition on human Helicobacter pylori gastritis: mechanisms underlying gastrointestinal safety and implications for cancer chemoprevention. Scheiman JM; Greenson JK; Lee J; Cryer B Aliment Pharmacol Ther; 2003 Jun; 17(12):1535-43. PubMed ID: 12823157 [TBL] [Abstract][Full Text] [Related]
14. Seven-Day Bismuth-based Quadruple Therapy as an Initial Treatment for Helicobacter pylori Infection in a High Metronidazole Resistant Area. Vilaichone RK; Prapitpaiboon H; Gamnarai P; Namtanee J; Wongcha-um A; Chaithongrat S; Mahachai V Asian Pac J Cancer Prev; 2015; 16(14):6089-92. PubMed ID: 26320500 [TBL] [Abstract][Full Text] [Related]
15. Association of gastric metaplasia and duodenitis with Helicobacter pylori infection in children. Shabib SM; Cutz E; Drumm B; Sherman PM Am J Clin Pathol; 1994 Aug; 102(2):188-91. PubMed ID: 8042587 [TBL] [Abstract][Full Text] [Related]
16. Effect of Helicobacter pylori colonisation on gastric mucosal eicosanoid synthesis in patients taking non-steroidal anti-inflammatory drugs. Hudson N; Balsitis M; Filipowicz F; Hawkey CJ Gut; 1993 Jun; 34(6):748-51. PubMed ID: 8314505 [TBL] [Abstract][Full Text] [Related]
17. Relation of lactoferrin levels in gastric mucosa with Helicobacter pylori infection and with the degree of gastric inflammation. Nakao K; Imoto I; Ikemura N; Shibata T; Takaji S; Taguchi Y; Misaki M; Yamauchi K; Yamazaki N Am J Gastroenterol; 1997 Jun; 92(6):1005-11. PubMed ID: 9177520 [TBL] [Abstract][Full Text] [Related]
18. Pathogenesis of gastric metaplasia of the human duodenum: role of Helicobacter pylori, gastric acid, and ulceration. Khulusi S; Badve S; Patel P; Lloyd R; Marrero JM; Finlayson C; Mendall MA; Northfield TC Gastroenterology; 1996 Feb; 110(2):452-8. PubMed ID: 8566592 [TBL] [Abstract][Full Text] [Related]
19. Simple noninvasive method to test efficacy of drugs in the eradication of Helicobacter pylori infection: the example of combined bismuth subsalicylate and nitrofurantoin. Graham DY; Klein PD; Evans DG; Evans DJ; Alpert LC; Opekun A; Jerdack GR; Morgan DR Am J Gastroenterol; 1991 Sep; 86(9):1158-62. PubMed ID: 1882794 [TBL] [Abstract][Full Text] [Related]
20. [Treatment of peptic ulcer and gastritis associated with Helicobacter pylori]. López-Brea M; Alarcón T Enferm Infecc Microbiol Clin; 1995; 13(7):422-8. PubMed ID: 8519820 [No Abstract] [Full Text] [Related] [Next] [New Search]